---
figid: PMC6178832__nihms-986344-f0002
figlink: /pmc/articles/PMC6178832/figure/F2/
number: Figure 2
caption: Schematic representation of the molecular events downstream cytokines activating
  the JAK/STAT pathway, involved in ILC development and functions. Specific molecular
  mechanisms of gene regulation and JAK inhibitors are also illustrated. Briefly,
  different cytokines bind specific combinations of receptors. Once engaged, cytokine
  receptors undergo oligomerization, initiating the signal transduction. JAKs bind
  the intra-cytoplasmic tail of the receptor, dimerize, and transactivate each other.
  STATs are recruited and associate to JAKs resulting in STAT phosphorylation and
  activation. Phosphorylated STATs migrate to the nucleus, modulating gene expression
  through several mechanisms. As illustrated, a STAT dimer can bind DNA without any
  modulation of gene expression (neutral or opportunistic binding). Transcription
  is regulated instead through binding of different DREs, including, promoters and
  enhancers. STAT5 can also act as a tetramer, regulating expression of specific genes.
  Moreover, STATs can regulate gene expression by recruiting chromatin modifiers and/or
  inducing tri-dimensional reorganization of the DNA, promoting the juxtaposition
  of the proper elements necessary for the downstream gene transcription. Finally,
  JAK inhibitors and their specificity for JAKs are shown.
pmcid: PMC6178832
papertitle: 'JAK/STAT signaling in regulation of innate lymphoid cells: the gods before
  the guardians.'
reftext: Helena Stabile, et al. Immunol Rev. 2018 Nov;286(1):148-159.
pmc_ranked_result_index: '100914'
pathway_score: 0.8926845
filename: nihms-986344-f0002.jpg
figtitle: Molecular features of the JAK-STAT signaling pathway
year: '2018'
organisms: Homo sapiens
ndex: 58d284b6-df15-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6178832__nihms-986344-f0002.html
  '@type': Dataset
  description: Schematic representation of the molecular events downstream cytokines
    activating the JAK/STAT pathway, involved in ILC development and functions. Specific
    molecular mechanisms of gene regulation and JAK inhibitors are also illustrated.
    Briefly, different cytokines bind specific combinations of receptors. Once engaged,
    cytokine receptors undergo oligomerization, initiating the signal transduction.
    JAKs bind the intra-cytoplasmic tail of the receptor, dimerize, and transactivate
    each other. STATs are recruited and associate to JAKs resulting in STAT phosphorylation
    and activation. Phosphorylated STATs migrate to the nucleus, modulating gene expression
    through several mechanisms. As illustrated, a STAT dimer can bind DNA without
    any modulation of gene expression (neutral or opportunistic binding). Transcription
    is regulated instead through binding of different DREs, including, promoters and
    enhancers. STAT5 can also act as a tetramer, regulating expression of specific
    genes. Moreover, STATs can regulate gene expression by recruiting chromatin modifiers
    and/or inducing tri-dimensional reorganization of the DNA, promoting the juxtaposition
    of the proper elements necessary for the downstream gene transcription. Finally,
    JAK inhibitors and their specificity for JAKs are shown.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL15RA
  - JAK2
  - STAT1
  - TYK2
  - IFNAR2
  - STAT6
  - JAK1
  - STAT2
  - JAK3
  - IFNAR1
  - STAT4
  - IL23A
  - STAT3
  - IL12B
  - IL7
  - IRF9
  - IL23R
  - STAT5B
  - IL2RB
  - IL4
  - STAT5A
  - IL15
  - IL12A
  - IL12RB1
  - IL12RB2
  - Filgotinib
  - Upadacitinib
  - Oclacitinib
  - PF-04945842
  - Baricitinib
  - Ruxolitinib
  - Decernotinib
  - Tofacitinib
  - PF-06651600
  - BMS-986142
  - Crohn's disease
genes:
- word: IL-15Ra.
  symbol: IL15RA
  source: hgnc_symbol
  hgnc_symbol: IL15RA
  entrez: '3601'
- word: JAK2.
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: TYK2
  symbol: TYK2
  source: hgnc_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: IFNAR2
  symbol: IFNAR2
  source: hgnc_symbol
  hgnc_symbol: IFNAR2
  entrez: '3455'
- word: Jak
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: Jak
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: Jak
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: JAK3
  symbol: JAK3
  source: hgnc_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: IFNAR1
  symbol: IFNAR1
  source: hgnc_symbol
  hgnc_symbol: IFNAR1
  entrez: '3454'
- word: Jak
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: STAT4
  symbol: STAT4
  source: hgnc_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: IL-23
  symbol: IL-23
  source: hgnc_alias_symbol
  hgnc_symbol: IL23A
  entrez: '51561'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: IL-12
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12B
  entrez: '3593'
- word: IL-7
  symbol: IL-7
  source: hgnc_alias_symbol
  hgnc_symbol: IL7
  entrez: '3574'
- word: IRF9
  symbol: IRF9
  source: hgnc_symbol
  hgnc_symbol: IRF9
  entrez: '10379'
- word: IL-23R
  symbol: IL-23R
  source: hgnc_alias_symbol
  hgnc_symbol: IL23R
  entrez: '149233'
- word: STAT2
  symbol: STAT2
  source: hgnc_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT6
  symbol: STAT6
  source: hgnc_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: IL-2RB
  symbol: IL2RB
  source: hgnc_symbol
  hgnc_symbol: IL2RB
  entrez: '3560'
- word: IL-4
  symbol: IL-4
  source: hgnc_alias_symbol
  hgnc_symbol: IL4
  entrez: '3565'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: IL-15
  symbol: IL-15
  source: hgnc_alias_symbol
  hgnc_symbol: IL15
  entrez: '3600'
- word: IL-12
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12A
  entrez: '3592'
- word: IL-12RB1
  symbol: IL12RB1
  source: hgnc_symbol
  hgnc_symbol: IL12RB1
  entrez: '3594'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: IL-12RB2
  symbol: IL12RB2
  source: hgnc_symbol
  hgnc_symbol: IL12RB2
  entrez: '3595'
chemicals:
- word: Filgotinib
  source: ''
  identifier: ''
- word: Upadacitinib
  source: ''
  identifier: ''
- word: Oclacitinib
  source: MESH
  identifier: C588062
- word: PF-04945842
  source: MESH
  identifier: D010977
- word: Baricitinib
  source: MESH
  identifier: C000596027
- word: Ruxolitinib
  source: MESH
  identifier: C540383
- word: Decernotinib
  source: MESH
  identifier: C000596981
- word: Tofacitinib
  source: MESH
  identifier: C479163
- word: PF-06651600
  source: MESH
  identifier: D010977
- word: BMS-986142
  source: MESH
  identifier: C095300
diseases:
- word: Crohn's disease
  source: ''
  identifier: ''
---
